Navigation Links
IVD (In Vitro Diagnostic) Market by (Product Type, Applications and Technology) Worth $69.1 Billion by 2017 - New Report by MarketsandMarkets
Date:8/29/2013

(PRWEB) August 29, 2013

IVD (In Vitro Diagnostic) Market research report focuses on the various levels of analysis, namely, industry, market shares, value chain, PESTEL analysis, and company profiles, which together comprise and augment the basic views on the competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies, high growth regions and countries and their respective regulatory policies, government initiative, drivers, restraints, and opportunities.

Browse 178 market data tables and 50 figures spread through 421 pages and in-depth TOC on “In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017.” Download a free sample report for IVD (In Vitro Diagnostic) Market.

Early buyers will receive 10% customization on this report.

In vitro diagnostics has been an area of significant innovation over the last decade, translating the practice of medicine into process, throughout the world. The Americas and Europe are saturated markets for IVD reagents and devices. The developing regions including BRIC (Brazil, Russia, India, and China) countries are expected to form the new revenue pockets for this market. The rising economies of these countries are the major driver for the growth of the IVD market. In addition, the large population, increasing incidences of chronic diseases, growing demand for quality medical care, increase in healthcare spending, and government initiatives are some of the other key factors fuelling the growth of IVD market in these regions. For instance, the Brazilian government provides free healthcare services to its citizens in government hospitals; the federal government funds around 65% of public healthcare expenditure and the municipal and local sources fund the rest of the expenditure.

In order to take advantage of the favorable conditions in developing economies and to cater to high demand of IVD technologies, a number of IVD companies are investing in these emerging countries. For instance, in June 2011, Hologic, Inc. acquired TCT International Co. Ltd., a distributor of medical products in China, for $135 million. The acquisition strengthened Hologic’s brand leadership in the cervical cancer screening market in China.

Among the BRIC countries, China’s IVD market is estimated to grow at the highest CAGR in the next five years. Fast-paced economy, public screening initiatives, and investments in healthcare infrastructure are the main drivers contributing to the growth of the IVD market in China. The players in the IVD market are expanding their facilities in China in order to meet this anticipated demand. In addition to China, the Indian IVD market also demonstrated a robust growth over the past few years. On the basis of market size, it now ranks among the top ten countries in the global IVD market. India’s evolving IVD market offers remarkable growth opportunities due to factors such as the increase in healthcare affordability, growing incidence of lifestyle diseases (diabetes and cardiovascular problems), and the large population size. The growth has been witnessed particularly in segments such as clinical chemistry and molecular diagnostics.

The other emerging countries such as Brazil, Russia, and Mexico also are growing IVD markets that are attracting leading companies. The combined effort of government and public sectors to increase healthcare awareness has enabled Asia and the LATAM region to become an attractive market for IVD manufacturers and suppliers.

The molecular diagnostic segment is expected to witness tremendous growth in the near future. Aging population, a concurrent escalation in the prevalence of chronic diseases, and the need for detection of such diseases at early stages are the key factors stimulating the market growth. Several big market players such as Siemens Healthcare, Abbott Laboratories, Inc., and Roche Diagnostics Limited are trying to increase their market share in the molecular diagnostics segment. In addition, Immunochemistry, clinical chemistry, and hematology techniques are also observing double-digit growth in the market. Many in vitro diagnostics companies are investing in these high growth markets, in order to gain more profits and capture increasing share in the market.

Browse related reports

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html

Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including agriculture, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare-it
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Read the full story at http://www.prweb.com/releases/ivd-in-vitro-diagnostics/market/prweb11073779.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BUSM in vitro study identifies potential combination therapy for breast cancer
2. In vitro studies assess the optimal concentration of propolis as a radioprotector
3. Case Western Reserve researchers create short-term memories in-vitro
4. In vitro study finds digested formula, but not breast milk, is toxic to cells
5. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com
6. New study on Hepatitis C drug treatment in vivo and in vitro
7. ViVitro Labs Adds Real-Time Wear Tester to Their Line of Cardiovascular Device Testing Equipment
8. Some Oral Contraceptives May Reduce Pregnancy Chances in In Vitro Fertilization (IVF), According to New Research by CHR
9. Researchers identify novel approach to create red blood cells, platelets in vitro
10. Univ. of Maryland review finds mixed results for acupuncture to improve in vitro fertilization rates
11. In Vitro Diagnostics Market Will Reach USD 1.1 Billion by 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... In an article published April 16th on ... Botox and lip injections, which she underwent in order to feel more at home ... Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; many plastic ...
(Date:4/29/2016)... , ... April 29, 2016 , ... On Tuesday, April ... across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the ... Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations which ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Coast Dental Fort ... 2016, at its new location in the Exchange Furniture Mall at 112 Vilseck Road ... a 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... of patented products, announces the Gyrociser, an exercise invention which aids in proper ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Tie-up with Government hospitals as ... to save newborns   Fortis La Femme, ... collaboration with Breast Milk Foundation (BMF), a non-profit organization within ... Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that ... and should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
(Date:4/27/2016)... , April 27, 2016 ... ), a developer of a new generation of ... positive overall survival results for Paclical/Apealea in the ... 789 patients with epithelial ovarian cancer. These preliminary ... Paclical/Apealea in combination with carboplatin versus Taxol in ...
Breaking Medicine Technology: